Close
  Indian J Med Microbiol
 

Figure 1: (a) Start of the treatment with adalimumab (December 2015), (b) after 3 months monotherapy with adalimumab (March 2016), (c) after 22 months of adalimumab and 19 months of intense pulsed light and radiofrequency (October 2017), (d) after 17 months additional monotherapy with intense pulsed light and radiofrequency (March 2019)

Figure 1: (a) Start of the treatment with adalimumab (December 2015), (b) after 3 months monotherapy with adalimumab (March 2016), (c) after 22 months of adalimumab and 19 months of intense pulsed light and radiofrequency (October 2017), (d) after 17 months additional monotherapy with intense pulsed light and radiofrequency (March 2019)